Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-26 @ 3:09 AM
Study NCT ID:
NCT03524820
Status:
TERMINATED
Last Update Posted:
2022-08-04
First Post:
2018-03-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
Sponsor:
Hadassah Medical Organization
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-07
First Submit QC Date:
None
Study First Post Date:
2018-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-02
Last Update Post Date:
2022-08-04
Last Update Post Date Type:
ACTUAL